Filing Details
- Accession Number:
- 0001567619-18-007453
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 19:14:57
- Reporting Period:
- 2018-12-03
- Accepted Time:
- 2018-12-06 19:14:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598292 | Ecor1 Capital Fund Qualified, L.p. | 409 Illinois Street San Francisco CA 94158 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-12-03 | 48,182 | $13.97 | 4,108,467 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-12-04 | 54,645 | $13.08 | 4,163,112 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-12-06 | 17,079 | $13.49 | 4,180,919 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |